Gitlife Biotech LTD enters members' voluntary liquidation
Active Company no. 14690170 Incorporated Feb 2023 NE postcode area
3rd Floor Maybrook House, 27-35 Grainger Street, Newcastle Upon Tyne, NE1 5JE
The most recent insolvency notice for Gitlife Biotech LTD is an Appointment of liquidators (MVL), published 20 October 2026 in The London Gazette. The office holders are Andrew Little (IP No. 9668); Gillian Margaret Sayburn (IP No. 10830), appointed 7 October 2026. Its last accounts filed at Companies House, to 28 August 2026, showed total assets of £53k and net assets of £41k. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
As at 28 August 2026 · total exemption full accounts · unaudited · filed 1 month before the first insolvency notice
Total liabilities is not shown for this company: the filed balance sheet did not reconcile against the figures we could read, so the total would be incomplete.
Average employees during the period: 6
Insolvency notices (2)
-
Appointment of liquidators (MVL) 20 Oct 2026
GITLIFE BIOTECH LTD has appointed Andrew Little and Gillian Margaret Sayburn as liquidators in a members' liquidation on 7 October 2026.
-
Resolution for winding up (MVL) 20 Oct 2026
GITLIFE BIOTECH LTD has been voluntarily wound up and appointed Andrew Little and Gillian Margaret Sayburn as joint liquidators.
What happens next
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Owed money by Gitlife Biotech LTD?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is Gitlife Biotech LTD in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Gitlife Biotech LTD (company no. 14690170) is a Appointment of liquidators (MVL), published 20 October 2026 in The London Gazette.
What were Gitlife Biotech LTD's last filed accounts?
Gitlife Biotech LTD's last accounts filed at Companies House, to 28 August 2026, showed total assets of £53k, cash of £43k, net assets of £41k. For a distressed company the last filing often predates the insolvency by a year or more.
How many insolvency notices does Gitlife Biotech LTD have?
Gitlife Biotech LTD has 2 insolvency notices recorded in The London Gazette, the most recent being a Appointment of liquidators (MVL) on 20 October 2026.
What happens next?
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.